Literature DB >> 19843036

HLA class I antibodies provoke graft arteriosclerosis in human arteries transplanted into SCID/beige mice.

S Galvani1, N Augé, D Calise, J C Thiers, C Canivet, N Kamar, L Rostaing, M Abbal, F Sallusto, R Salvayre, T Böhler, Y Zou, P Stastny, A Nègre-Salvayre, M Thomsen.   

Abstract

Antibodies toward HLA class I and/or MICA are commonly observed in transplanted patients suffering from allograft arteriosclerosis, also called chronic vascular rejection (CVR). The relative importance of cellular versus humoral alloreactivity for CVR is still disputed. We demonstrate that antibodies toward HLA class I provoke lesions typical for CVR in human arteries in vivo in the absence of cellular immunity. To show this, we grafted segments of human mesenteric arteries from 8 deceased organ donors into 36 immunodeficient SCID/beige mice in the infrarenal aortic position. Three mice died postoperatively. The remaining 33 mice received weekly i.v. injections of either a monoclonal antibody toward HLA class I, toward MICA or an irrelevant monoclonal antibody. At sacrifice after 6 weeks, mice receiving the HLA antibody showed a significant neointimal thickening in the grafted artery due to smooth muscle cell (SMC) proliferation while control mice receiving anti-MICA or irrelevant antibody showed little or no thickening. Whereas antibodies toward HLA class I were mitogenic to SMC in vitro, those directed toward MICA did not have any effect. Humoral alloreactivity toward HLA may thus play a causal role for the development of CVR and this opens new possibilities for the treatment of CVR.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19843036     DOI: 10.1111/j.1600-6143.2009.02804.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  18 in total

1.  A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody.

Authors:  T Hirohashi; C M Chase; P Della Pelle; D Sebastian; A Alessandrini; J C Madsen; P S Russell; R B Colvin
Journal:  Am J Transplant       Date:  2011-11-09       Impact factor: 8.086

2.  Antibody ligation of human leukocyte antigen class I molecules stimulates migration and proliferation of smooth muscle cells in a focal adhesion kinase-dependent manner.

Authors:  Fang Li; Xiaohai Zhang; Yi-Ping Jin; Arend Mulder; Elaine F Reed
Journal:  Hum Immunol       Date:  2011-10-01       Impact factor: 2.850

Review 3.  Antibody-mediated rejection: emergence of animal models to answer clinical questions.

Authors:  William M Baldwin; Anna Valujskikh; Robert L Fairchild
Journal:  Am J Transplant       Date:  2010-03-19       Impact factor: 8.086

Review 4.  The link between major histocompatibility complex antibodies and cell proliferation.

Authors:  Nicole M Valenzuela; Elaine F Reed
Journal:  Transplant Rev (Orlando)       Date:  2011-07-30       Impact factor: 3.943

Review 5.  Recent advances in allograft vasculopathy.

Authors:  Jonathan Merola; Daniel D Jane-Wit; Jordan S Pober
Journal:  Curr Opin Organ Transplant       Date:  2017-02       Impact factor: 2.640

Review 6.  Interacting mechanisms in the pathogenesis of cardiac allograft vasculopathy.

Authors:  Jordan S Pober; Dan Jane-wit; Lingfeng Qin; George Tellides
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-06-05       Impact factor: 8.311

Review 7.  HLA class I antibody-mediated endothelial and smooth muscle cell activation.

Authors:  Xiaohai Zhang; Nicole M Valenzuela; Elaine F Reed
Journal:  Curr Opin Organ Transplant       Date:  2012-08       Impact factor: 2.640

8.  Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through noncanonical nuclear factor-κB signaling in endothelial cells.

Authors:  Dan Jane-Wit; Thomas D Manes; Tai Yi; Lingfeng Qin; Pamela Clark; Nancy C Kirkiles-Smith; Parwiz Abrahimi; Julie Devalliere; Gilbert Moeckel; Sanjay Kulkarni; George Tellides; Jordan S Pober
Journal:  Circulation       Date:  2013-09-17       Impact factor: 29.690

9.  Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury.

Authors:  Nicole M Valenzuela; Elaine F Reed
Journal:  Methods Mol Biol       Date:  2013

Review 10.  MHC class I signaling: new functional perspectives for an old molecule.

Authors:  E W Tsai; E F Reed
Journal:  Tissue Antigens       Date:  2014-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.